ArticleCNS neuroscience & therapeutics2026
1 Hz Low-Frequency Repetitive Transcranial Magnetic Stimulation Ameliorates Epilepsy by Suppressing Interferon-γ Signaling-Dependent Microglial Synaptic Phagocytosis in Mice.
Article in CNS neuroscience & therapeutics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
aimsWe aim to investigate the impact of low-frequency repetitive transcranial magnetic stimulation (LF-rTMS) on activated microglia in temporal lobe epilepsy (TLE), which exacerbate seizures and memory problems, and to explore the molecular mechanisms and clinical potential of LF-rTMS for TLE treatment.
methodsWe tested 0.3, 0.5, 1 Hz LF-rTMS in kainic acid (KA)-induced TLE mice, assessing EEG, inflammation, synaptic phagocytosis, memory, scRNA-seq, and IFN-γ neutralizing antibodies. SnRNA-seq of human hippocampal sclerosis (HS) tissues confirmed relevance.
resultsIn KA-induced TLE mice, 1 Hz LF-rTMS decreased seizures, neuroinflammation, and hippocampal synaptic phagocytosis, while enhancing memory. These effects were linked to increased microglial IFN-γ signaling (activating STAT2 and inhibiting CADM1/2/3), which were negated by IFN-γ blockade. SnRNA-seq of human HS tissues revealed elevated IFN-γ signaling in DAM-like cells, indicating clinical relevance.
conclusionOur study indicates that 1 Hz LF-rTMS is a promising treatment for TLE, potentially reducing seizures and cognitive issues by affecting microglial function. Our findings show that IFN-γ signaling triggers STAT2 activation, which is strongly linked to the increased expression of IFN-γ signature DAM and the decreased expression of CADM1/2/3 in DAM, thus playing a role in the neuroprotective effects of 1 Hz LF-rTMS. These findings reveal a new LF-rTMS mechanism and offer insights for targeted therapies in drug-resistant epilepsy.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.